DIMETHYL FUMARATE MEDOMIE 240 MG

Land: Israel

Sprog: engelsk

Kilde: Ministry of Health

Køb det nu

Indlægsseddel Indlægsseddel (PIL)
11-10-2022

Aktiv bestanddel:

DIMETHYL FUMARATE

Tilgængelig fra:

MEDOMIE PHARMA LTD, ISRAEL

ATC-kode:

N07XX09

Lægemiddelform:

CAPSULES DELAYED RELEASE

Sammensætning:

DIMETHYL FUMARATE 240 MG

Indgivelsesvej:

PER OS

Recept type:

Required

Fremstillet af:

MSN LABORATORIES PRIVATE LIMITED, INDIA

Terapeutisk område:

DIMETYL FUMARATE

Terapeutiske indikationer:

Indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Autorisation dato:

2022-07-05

Indlægsseddel

                                Dimethyl Fumarate Medomie-PIL-0722-V1
Dimethyl_fumarate_Medomie_120_mg_240_mg-PIL-ENG-D7-F
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS' REGULATIONS
(PREPARATIONS) - 1986
This medicine is dispensed with a doctor’s prescription only.
DIMETHYL FUMARATE MEDOMIE 120 MG
DIMETHYL FUMARATE MEDOMIE 240 MG
DELAYED RELEASE CAPSULES
ACTIVE INGREDIENT AND ITS QUANTITY:
Each capsule contains: 120 mg or 240 mg dimethyl fumarate
Inactive ingredients and allergens: see section 6 'Additional
information'.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE. This leaflet contains
concise information about this medicine. If you have any further
questions, consult your doctor
or pharmacist. _ _
This medicine has been prescribed to treat your illness. Do not pass
it on to others. It may
harm them, even if it seems to you that their illness is similar to
yours.
This medicine is not indicated for use in children below the age of
18. There is no information
about the safety and efficacy of Dimethyl Fumarate Medomie in this age
group.
1.
WHAT IS THIS MEDICINE INTENDED FOR?
Dimethyl Fumarate Medomie is indicated for the treatment of adult
patients with relapsing
remitting multiple sclerosis.
THERAPEUTIC GROUP: A medicine that affects the nervous system.
Multiple sclerosis is a chronic disease that affects the central
nervous system, including the
brain and the spinal cord. Relapsing-remitting multiple sclerosis is
characterised by repeated
attacks (relapses) of nervous system symptoms. Symptoms vary from
patient to patient, but
typically include walking difficulties, feeling off balance and visual
difficulties (e.g., blurred or
double vision). These symptoms may disappear completely when the
relapse is over, but
some problems may remain.
HOW DIMETHYL FUMARATE MEDOMIE WORKS
Dimethyl Fumarate Medomie seems to work by preventing the immune
system from damaging
your brain and spinal cord. This may also prevent future deterioration
of your disease.
2.
BEFORE USING THIS MEDICINE
DO NOT USE THIS MEDICINE IF:
•
You ar
                                
                                Læs hele dokumentet
                                
                            

Dokumenter på andre sprog

Indlægsseddel Indlægsseddel arabisk 11-10-2022
Indlægsseddel Indlægsseddel hebraisk 27-12-2023

Søg underretninger relateret til dette produkt